Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

5
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (1)

Searched Name

Pentasa

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Expanded table: Some drugs for inflammatory bowel disease. Med Lett Drugs Ther 2023;65:e115-e119. [PMID: 37418332 DOI: 10.58347/tml.2023.1680d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/09/2023] Abstract Expanded Table: Some Drugs for Inflammatory Bowel Disease Collapse Key Words Amjevita Apriso Asacol Avsola Azasan Azulfidine Canasa Cimzia Colazal Cortenema Cortifoam Crohn's disease Delzicol Entyvio Imuran Inflectra Lialda Ortikos Pentasa Rayos Remicade Renflexis Rinvoq Rowasa Simponi Skyrizi Stelara TNF inhibitors Uceris Xeljanz Zeposia adalimumab adverse effects aminosalicylates azathioprine balsalazide budesonide certolizumab corticosteroids dosage golimumab hydrocortisone inflammatory bowel disease infliximab mercaptopurine mesalamine methotrexate olsalazine ozanimod prednisone risankizumab safety sulfasalazine tofacitinib ulcerative colitis upadacitinib ustekinumab vedolizumab Collapse MESH Headings Humans Inflammatory Bowel Diseases/drug therapy Immunosuppressive Agents Colitis, Ulcerative Collapse Grants Collapse Affiliation(s) Collapse
2	Drugs for inflammatory bowel disease. Med Lett Drugs Ther 2023;65:105-112. [PMID: 37418329 DOI: 10.58347/tml.2023.1680a] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 07/09/2023] Abstract Ulcerative colitis (UC) and Crohn’s disease (CD), referred to collectively as inflammatory bowel disease (IBD), are chronic immune-mediated inflammatory conditions. Guidelines for treatment of UC and CD have been updated in recent years. Collapse Key Words Apriso Asacol Azasan Azulfidine Canasa Cimzia Colazal Cortenema Cortifoam Crohn's disease Delzicol Dipentum Entyvio Humira Imuran Lialda Ortikos Pentasa Rayos Remicade Rinvoq Rowasa Simponi Skyrizi Stelara TNF inhibitors Tysabri Uceris Xeljanz Zeposia adalimumab adverse effects aminosalicylates azathioprine balsalazide budesonide certolizumab corticosteroids dosage efficacy golimumab hydrocortisone inflammatory bowel disease infliximab mercaptopurine mesalamine methotrexate natalizumab olsalazine ozanimod prednisone risankizumab safety sulfasalazine tofacitinib ulcerative colitis upadacitinib ustekinumab vedolizumab Collapse MESH Headings Humans Inflammatory Bowel Diseases/drug therapy Immunosuppressive Agents Colitis, Ulcerative Infliximab Collapse Grants Collapse Affiliation(s) Collapse
3	Ozanimod (Zeposia) for ulcerative colitis. Med Lett Drugs Ther 2021;63:147-51. [PMID: 34550962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023] Abstract Collapse Key Words Amgevita Apriso Asacol Avsola Azasan Azulfidine Colazal Cortiment Delzicol Dipentum Entyvio Hadlima Hulio Humira Hyrimoz Idacio Imuran Inflectra Lialda Mezavant Pentasa Purixan Rayos Remicade Renflexis Salazopyrin Salofalk Simponi Stelara TNF inhibitors Uceris Xeljanz Zeposia adalimumab adverse effects aminosalicylates azathioprine balsalazide budesonide corticosteroids dosage drug interactions efficacy golimumab infliximab lactation mercaptopurine mesalamine mesalazine olsalazine ozanimod prednisone pregnancy safety sulfasalazine tofacitinib ulcerative colitis ustekinumab vedolizumab Collapse MESH Headings Colitis, Ulcerative/drug therapy Double-Blind Method Drug Approval Drug Interactions Gastrointestinal Agents/administration & dosage Gastrointestinal Agents/adverse effects Gastrointestinal Agents/therapeutic use Humans Indans/administration & dosage Indans/adverse effects Indans/therapeutic use Oxadiazoles/administration & dosage Oxadiazoles/adverse effects Oxadiazoles/therapeutic use Randomized Controlled Trials as Topic Severity of Illness Index United States United States Food and Drug Administration Collapse Grants Collapse Affiliation(s) Collapse
4	Comparison table: some drugs for inflammatory bowel disease. Med Lett Drugs Ther 2018;60:e117-22. [PMID: 30036356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023] Abstract Collapse Key Words Apriso Asacol Azasan Azulfidine Canasa Cimzia Colazal Colocort Cortenema Cortifoam Delzicol Dipentum Entocort Entyvio Giazo Humira Imuran Inflectra Ixifi Lialda Otrexup Pentasa Purixan Rasuvo Rayos Remicade Renflexis Rowasa Sandimmune Simponi Stelara TNF inhibitors Tysabri Uceris Xeljanz adalimumab aminosalicylates azathioprine balsalazide budesonide certolizumab corticosteroids cyclosporine golimumab hydrocortisone inflammatory bowel disease infliximab mercaptopurine mesalamine methotrexate natalizumab olsalazine prednisone sulfasalazine tofacitinib ustekinumab vedolizumab Collapse MESH Headings Gastrointestinal Agents/administration & dosage Gastrointestinal Agents/adverse effects Gastrointestinal Agents/therapeutic use Humans Immunosuppressive Agents/administration & dosage Immunosuppressive Agents/adverse effects Immunosuppressive Agents/therapeutic use Inflammatory Bowel Diseases/drug therapy Interleukins/antagonists & inhibitors Janus Kinase Inhibitors/therapeutic use Tumor Necrosis Factor-alpha/antagonists & inhibitors Collapse Grants Collapse Affiliation(s) Collapse
5	Drugs for inflammatory bowel disease. Med Lett Drugs Ther 2018;60:107-14. [PMID: 30036352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023] Abstract Collapse Key Words Aminosalicylates Antibiotics Apriso Asacol Azasan Azulfidine Betnesol Canasa Cimzia Colazal Colocort Cortenema Corticosteroids Cortifoam Cortiment Crohn's disease Cyclosporine Delzicol Dipentum Entocort Entyvio Giazo Hadima Humira Imuran Inflectra Integrin Receptor Antagonists Interleukin (Il)-12 and -23 Antagonist Ixifi JAK Inhibitor Janus Kinase Inhibitor Lialda Methotrexate Metoject Mezavant Otrexup Pentasa Purixan Rasuvo Rayos Remicade Renflexis Rowasa Salazopyrin Salofalk Sandimmune Simponi Stelara TNF Inhibitors TNF inhibitors Thiopurines Tysabri Uceris VSL Xeljanz adalimumab adverse effects aminosalicylates antibacterials azathioprine balsalazide betamethasone budesonide certolizumab corticosteroids cyclosporine dosage drug interactions efficacy golimumab hydrocortisone inflammatory bowel disease infliximab mercaptopurine mesalamine mesalazine methotrexate natalizumab olsalazine prednisone probiotics sulfasalazine tofacitinib ulcerative colitis ustekinumab vedolizumab Collapse MESH Headings Gastrointestinal Agents/administration & dosage Gastrointestinal Agents/adverse effects Gastrointestinal Agents/therapeutic use Humans Immunosuppressive Agents/administration & dosage Immunosuppressive Agents/adverse effects Immunosuppressive Agents/therapeutic use Inflammatory Bowel Diseases/drug therapy Interleukins/antagonists & inhibitors Janus Kinase Inhibitors/therapeutic use Tumor Necrosis Factor-alpha/antagonists & inhibitors Collapse Grants Collapse Affiliation(s) Collapse